None listed
Conditions
Interventions
Intervention1: BCG vaccine injection first followed by HepatitisB vaccine injection: 0.1 ml of BCG vaccine (TUBERVAC?) was administered intradermally at the convex aspect of the left shoulder using a
Sponsors
SR Ravikiran
Eligibility
Inclusion criteria
Inclusion criteria: Randomized study of full term healthy newborns who received the routine dose of BCG and the Hepatitis-B vaccine in the vaccination room of Pediatric Department; KVG Medical College Hospital; Sullia.
Exclusion criteria
Exclusion criteria: We excluded sick newborns , 5 minute APGAR<7, low birth weight babies, and those who were discharged before the weekly vaccination day.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure was the neonatal pain. Pain assessment was done using the neonatal infant pain scale (NIPS).Timepoint: it was measured prior to the vaccine injections and during the vaccine injections. | — |
Secondary
| Measure | Time frame |
|---|---|
| 10-cm visual analog scale (VAS)Timepoint: Obtained immediately after the first and second vaccine injections. | — |
Countries
India
Contacts
Public ContactSR Ravikiran
Outcome results
None listed